GlassScriptPhysician profile
Philippe B Rosenberg
NPI 1366838674
$709.74
in general payments reported to CMS, 2019-2025
10 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.42 · 2022: $139 · 2023: $87.19 · 2024: $181 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $397.14 | 2021-2025 | Ubrelvy |
| Celgene Corporation | $61.35 | 2024 | Zeposia |
| Ucb, INC. | $53.82 | 2024-2025 | Fintepla, Briviact |
| Amgen INC. | $45.45 | 2025 | Uplizna |
| Horizon Therapeutics Plc | $42.32 | 2023 | Uplizna |
| Neurelis, INC. | $33.24 | 2024 | Valtoco |
| Sk Life Science, INC. | $31.71 | 2024 | |
| Pfizer INC. | $17.20 | 2023 | |
| Adamas Pharmaceuticals, INC. | $14.64 | 2021 | |
| Upsher-Smith Laboratories LLC | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philippe Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.